The Bioprocessing Summit Europe 2026 took place in Barcelona from March 10–12, 2026. The event featured three dedicated panel discussions with 10 named panelists covering data and AI in bioprocessing, cell therapy manufacturing, and oligonucleotide manufacturing.
The official event name was Bioprocessing Summit Europe 2026. Because the event was held in Barcelona, it may also be searched as “Bioprocessing Summit Barcelona 2026.” This page focuses specifically on the panelists and moderators identified in the official 2026 program.
| Information | Details |
|---|---|
| Official Event Name | Bioprocessing Summit Europe 2026 |
| Location | Barcelona, Spain |
| Dates | March 10–12, 2026 |
| Panel Discussions | 3 |
| Confirmed Panelists | 10 |
| Main Topics | Data & AI, Cell Therapy Manufacturing, Oligonucleotide Manufacturing |
| # | Panelist | Position | Organization | Panel |
|---|---|---|---|---|
| 1 | Andrea Arsiccio, PhD | Senior Scientist & Team Lead, In Silico | Coriolis Pharma Research GmbH | Unlocking Smarter Bioprocessing |
| 2 | Ayca Cetinkaya, PhD | Senior Scientist | AstraZeneca | Unlocking Smarter Bioprocessing |
| 3 | Mario P. Pereira, PhD | Director, Technology & Business Development | ATUM | Unlocking Smarter Bioprocessing |
| 4 | Jack Prior, PhD | Head, Process Monitoring & Data Science & AI | Sanofi | Unlocking Smarter Bioprocessing |
| 5 | Ian Rees | Assessor | MHRA | Manufacturing and Delivering Cell Therapies |
| 6 | Vered Caplan | CEO, Octomera; CEO, Orgenesis | Octomera / Orgenesis | Manufacturing and Delivering Cell Therapies |
| 7 | Manel Juan Otero | Head, Clinical Immunology | Sant Joan de Deu Barcelona Hospital | Manufacturing and Delivering Cell Therapies |
| 8 | Xiaolei Zhuang, PhD | Scientific Liaison, Global Biologics | USP | Innovations in Oligonucleotide Manufacturing |
| 9 | Barrie Cassey, PhD | Manufacturing Technology Consultant | Invox | Innovations in Oligonucleotide Manufacturing |
| 10 | Dennis Rhodes | Associate Director, Analytical Development and QC | Ionis Pharmaceuticals Inc. | Innovations in Oligonucleotide Manufacturing |
The Bioprocessing Summit Europe 2026 program featured 10 panelists across three panel discussions. The panelists represented pharmaceutical companies, bioprocessing technology organizations, regulatory bodies, healthcare institutions, and biotechnology companies.
Panel: Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
The first panel focused on how better data collection, data quality, analysis, and digital approaches can support modern bioprocess development and decision-making. The discussion brought together professionals with experience spanning bioprocess modelling, pharmaceutical research, technology development, and process monitoring.
Position: Senior Scientist & Team Lead, In Silico
Organization: Coriolis Pharma Research GmbH
Panel: Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
Position: Senior Scientist
Organization: AstraZeneca
Panel: Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
Position: Director, Technology & Business Development
Organization: ATUM
Panel: Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
Position: Head, Process Monitoring & Data Science & AI Strategy
Organization: Sanofi
Panel: Unlocking Smarter Bioprocessing through Better Data Collection, Quality, and Analysis
Panel: Manufacturing and Delivering Cell Therapies to Patients
The second panel examined challenges associated with manufacturing and delivering cell therapies, including regulatory considerations, decentralised manufacturing, and point-of-care approaches. The panel brought together perspectives from regulation, biotechnology, and clinical immunology.
Position: Assessor, Innovation and Compliance
Organization: MHRA
Panel: Manufacturing and Delivering Cell Therapies to Patients
Position: CEO
Organization: Octomera; Orgenesis
Panel: Manufacturing and Delivering Cell Therapies to Patients
Position: Head, Clinical Immunology
Organization: Sant Joan de Deu Barcelona Hospital
Panel: Manufacturing and Delivering Cell Therapies to Patients
Panel: Innovations in Oligonucleotide Manufacturing
Position: Scientific Liaison, Global Biologics
Organization: United States Pharmacopeia (USP)
Panel: Innovations in Oligonucleotide Manufacturing
Position: Manufacturing Technology Consultant
Organization: Invox
Panel: Innovations in Oligonucleotide Manufacturing
Position: Associate Director, Analytical Development and QC
Organization: Ionis Pharmaceuticals Inc.
Panel: Innovations in Oligonucleotide Manufacturing
| Moderator | Organization | Panel |
|---|---|---|
| Maximilian Krippl, PhD | Novasign GmbH | Unlocking Smarter Bioprocessing |
| Christopher Bravery, PhD | Advanced Biologicals Ltd. | Manufacturing and Delivering Cell Therapies to Patients |
| Hagen Cramer, PhD | QurAlis Corporation | Innovations in Oligonucleotide Manufacturing |
The first panel examined how data-driven technologies, artificial intelligence, and computational approaches are being applied to bioprocess development and process optimization.
The second panel addressed the challenges involved in manufacturing and delivering cell therapies, including the requirements associated with moving cell-based treatments toward patients.
The third panel focused on innovations and challenges in oligonucleotide manufacturing and the evolving production requirements for oligonucleotide-based therapies.
The 10 panelists featured on this page represent only a small portion of the professionals who participated in the summit. To view the professionals and organizations that attended the summit, check out our Bioprocessing Summit Europe 2026 Attendee List.
The attendee database holds professionals working in pharma and biotech companies, providers of bioprocessing tech, research and academic groups, manufacturing firms, and other companies operating in life science.
Visit the Bioprocessing Summit Europe 2026 Attendee List to review the attendees and understand how the attendees data can boost your business growth through sales, marketing, research, and tailored reach-out activities.